Brought to you by 
Actelion Pharmaceuticals takes 20.1% stake in EchoSense
12 Jun 2013
Executive Summary
For CHF4.5mm ($5.1mm), Actelion Pharmaceuticals Ltd. (markets products for orphan diseases) has taken a 20.1% equity stake in Israeli device company EchoSense Ltd. This represents Actelion’s first major investment in devices.
Deal Industry
- Medical Devices
-
Medical Devices
- Diagnostic Equipment & Supplies
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Therapeutic Drug Monitoring
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Actelion Pharmaceuticals takes 20.1% stake in EchoSense
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice